Immunic | VTL - Cash And Equivalent


Immunic reported $35.13M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
BioMarin Pharmaceutical USD 1.31B 61.57M Dec/2025
Cipla INR 7.96B 39.9M Sep/2025
Clal Biotechnology ILS 5.73M 1.71M Dec/2023
Compugen USD 90.6M 83.14M Dec/2025
CSL USD 2.16B 633M Jun/2025
Enanta Pharmaceuticals USD 37.44M 5.14M Dec/2025
Grifols EUR 979.78M 334.84M Dec/2024
Immunic USD 35.13M 20.18M Sep/2025
Insmed USD 510.44M 175.68M Dec/2025
Omeros USD 1.9M 2.36M Jun/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Quidel USD 169.8M 71.7M Dec/2025
Ultragenyx Pharmaceutical USD 202.51M 36.4M Sep/2025
United Therapeutics USD 1.56B 217M Dec/2025
Xoma USD 143.9M 7.68M Jun/2024